Table 1.
Sample characteristics and bivariate correlations with study outcomes
| Descriptives | Bivariate correlations | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FACT-B | PWB | SWB | EWB | FWB | BCC | BCPT | IES-T | IES-I | IES-A | ||
| Sociodemographic factors | |||||||||||
| Age, years; M (SD) | 52.61 (11.28) | − 0.07 | 0.05 | − 0.19† | − 0.02 | − 0.20† | 0.03 | − 0.08 | − 0.08 | − 0.10 | − 0.05 |
| English language; n (%) | 35 (36.8) | 0.04 | − 0.03 | 0.24* | 0.02 | 0.07 | − 0.08 | 0.27** | − 0.04 | − 0.01 | − 0.05 |
| Mexican ancestry; n (%) | 62 (65.3) | − 0.13 | − 0.16 | − 0.05 | − 0.23* | − 0.06 | 0.05 | − 0.02 | 0.19† | 0.23* | 0.11 |
| U.S. born; n (%) | 30 (31.6) | − 0.01 | − 0.05 | 0.11 | − 0.02 | 0.02 | − 0.05 | 0.23* | 0.08 | 0.01 | 0.13 |
| Education > high school; n (%) | 42 (44.2) | 0.20† | 0.11 | 0.21* | 0.20† | 0.23* | 0.02 | − 0.07 | − 0.15 | − 0.11 | − 0.16 |
| Annual household income ≥ $25,000; n (%) | 49 (51.6) | 0.12 | − 0.05 | 0.24* | 0.04 | 0.24* | 0.03 | 0.08 | − 0.22* | − 0.14 | − 0.26* |
| Employed; n (%) | 43 (45.3) | 0.11 | 0.08 | − 0.02 | 0.04 | 0.21* | 0.11 | − 0.09 | − 0.17 | − 0.10 | − 0.20† |
| Married; n (%) | 59 (62.1) | 0.24* | 0.11 | 0.30** | 0.14 | 0.19† | 0.17 | 0.05 | 0.05 | 0.10 | − 0.01 |
| Cancer-related factors | |||||||||||
| Stage of disease; n (%) | − 0.04 | 0.11 | − 0.22* | 0.06 | − 0.20† | − 0.03 | − 0.03 | 0.04 | 0.04 | 0.06 | |
| 0 | 2 (2.1) | ||||||||||
| I | 26 (27.4) | ||||||||||
| II | 36 (37.9) | ||||||||||
| III | 15 (15.8) | ||||||||||
| Had surgery; n (%) | 95 (100) | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Received chemotherapy; n (%) | 55 (57.9) | − 0.14 | − 0.15 | 0.03 | − 0.07 | − 0.08 | − 0.21* | 0.09 | 0.07 | 0.06 | 0.07 |
| Received radiation; n (%) | 69 (72.6) | − 0.16 | − 0.10 | − 0.13 | − 0.12 | − 0.18† | − 0.08 | 0.11 | 0.03 | 0.11 | − 0.04 |
| Hormone therapy; n (%) | 72 (75.8) | 0.08 | 0.15 | − 0.06 | − 0.00 | 0.09 | 0.09 | − 0.17 | − 0.13 | − 0.15 | − 0.09 |
| Time (number of days) since treatment completion; M (SD) | 355.45 (242.02) | − 0.31** | − 0.32** | − 0.04 | − 0.44** | − 0.03 | − 0.20† | 0.14 | − 0.10 | − 0.06 | − 0.12 |
Total sample size: N = 95. Bivariate correlations were Pearson, point biserial, or Spearman’s rank-order correlations, as appropriate. n frequency, M mean, SD standard deviation, FACT-B Functional Assessment of Cancer Therapy-Breast, PWB physical well-being, SWB social well-being, EWB emotional well-being, FWB functional well-being, BCC breast cancer concerns, BCPT Breast Cancer Prevention Trial, IES-T Impact of Events Scale (IES) total score, IES-I IES Intrusion, IES-A IES Avoidance.
*
p < 0.05;
**
p < 0.01;
***
p < 0.001;
†
p < 0.10